(Q39449262)

12 September 2017

title

Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1. (English)

1 reference

12 September 2017

0 references

Peiqing Shi

1

1 reference

12 September 2017

Shu Zhu

2

1 reference

12 September 2017

Yingying Lin

3

1 reference

12 September 2017

Yongfeng Liu

4

1 reference

12 September 2017

Yan Liu

5

1 reference

12 September 2017

Zhijian Chen

6

1 reference

12 September 2017

Yufang Shi

7

1 reference

12 September 2017

Youcun Qian

8

1 reference

12 September 2017

publication date

1 November 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

4

1 reference

12 September 2017

issue

197

1 reference

12 September 2017

page(s)

ra73

1 reference

Th17: the third member of the effector T cell trilogy

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Transcriptional regulation of Th17 cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Th17 cell differentiation: the long and winding road

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

The biological functions of T helper 17 cell effector cytokines in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Signal transduction and Th17 cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Structure and signalling in the IL-17 receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Interleukin-17 family and IL-17 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

IL-17 signaling in host defense and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

IL-17 signaling-independent central nervous system autoimmunity is negatively regulated by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

TH17 cells in asthma and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

An overview of IL-17 function and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

A role for the cytoplasmic adaptor protein Act1 in mediating IL-17 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Act1, a U-box E3 ubiquitin ligase for IL-17 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Ubiquitin ligases: cell-cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Ubiquitylation in innate and adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Identification of the receptor component of the IkappaBalpha-ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

The ubiquitin system: pathogenesis of human diseases and drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Polyubiquitin chains: polymeric protein signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

IL-17-induced NF-kappaB activation via CIKS/Act1: physiologic significance and signaling mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Differential regulation of the IL-17 receptor by gammac cytokines: inhibitory signaling by the phosphatidylinositol 3-kinase pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Missing pieces in the NF-kappaB puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

Oscillations in NF-kappaB signaling control the dynamics of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2001653

10.1126/SCISIGNAL.2001653

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference